| Literature DB >> 33420827 |
Jianhua Chen1, Yanwu Sun2, Pan Chi2, Bin Sun3.
Abstract
PURPOSE: Laparoscopic total mesorectal excision (LaTME) is technically demanding in rectal cancer after neoadjuvant chemoradiotherapy (NCRT). This study aimed to predict the surgical difficulty of LaTME after NCRT based on pelvimetric parameters.Entities:
Keywords: Chemoradiotherapy; Laparoscopic surgery; Magnetic resonance; Pelvimetry; Rectal cancer
Year: 2021 PMID: 33420827 PMCID: PMC8215037 DOI: 10.1007/s00595-020-02211-3
Source DB: PubMed Journal: Surg Today ISSN: 0941-1291 Impact factor: 2.549
Fig. 1Images showing the MRI-based pelvimetric parameters. a Sagittal MRI showing the pelvic inlet (A), pubic tubercle height (B), pelvic outlet length (C), sacral length (D), sacral depth (E), and pelvic depth (F). b Sagittal MRI illustrating the pelvic angles (α, β, γ, and δ). c Axial MRI showing the interspinous distance. d Axial MRI showing the manual tracing of the circumference of the rectum (1), which represented the rectal area; axial MRI showing the manual tracing of the circumference of the mesorectum (2), which represented the mesorectal area
Baseline characteristics of LARC patients following NCRT and LaTME
| Characteristics | Values |
|---|---|
| Age (years) | 56.4 ± 11.6 |
| BMI (kg/m2) | 23.1 ± 2.9 |
| Distance from the anal verge (cm) | 6.8 ± 2.0 |
| Tumor diameter (cm) | 2.0 ± 1.0 |
| Prior abdominal surgery | 10 (6.8%) |
| Time interval from completion of radiation to surgery (week) | 9.3 ± 4.3 |
| Surgical procedure | |
| LAR | 52 (35.4%) |
| ULAR | 77 (52.4%) |
| ISR | 18 (12.2%) |
| Operative time (min) | 227.5 ± 63.2 |
| Estimated blood loss (ml) | 70.9 ± 72.5 |
| Conversion to open procedure | 3 (2%) |
| Use of transanal dissection | 3 (2%) |
| Postoperative hospital stay (days) | 7.7 ± 3.8 |
| Postoperative complications | 23 (15.6%) |
| Pathological TNM stage | |
| 0 | 30 (20.4%) |
| I | 36 (24.5%) |
| II | 32 (21.8%) |
| III | 49 (33.3%) |
| Lymph node harvested | 13.8 ± 7.2 |
Data are described as the number (percentage) or as the median ± standard deviation
LARC locally advanced rectal cancer, NCRT neoadjuvant chemoradiotherapy, LaTME laparoscopic total mesorectal excision, BMI body mass index, LAR low anterior resection, ULAR ultra-low anterior resection, ISR intersphincteric resection, TNM tumor node metastasis
Pelvimetry parameters in LARC patients following NCRT
| Parameters | Total ( | Surgical difficulty | ||
|---|---|---|---|---|
| Low ( | High ( | |||
| Pelvic inlet length (cm) | 11.3 ± 0.9 | 11.3 ± 1.0 | 11.5 ± 0.8 | 0.346 |
| Pubic tubercle height (cm) | 5.2 ± 0.3 | 5.2 ± 0.3 | 5.2 ± 0.4 | 0.848 |
| Pelvic outlet length (cm) | 7.9 ± 0.6 | 7.8 ± 0.6 | 8.0 ± 0.6 | 0.300 |
| Sacral length (cm) | 12.3 ± 1.1 | 12.3 ± 1.2 | 12.3 ± 0.9 | 0.849 |
| Sacral depth (cm) | 3.8 ± 0.4 | 3.8 ± 0.5 | 3.7 ± 0.4 | 0.403 |
| Pelvic depth (cm) | 10.9 ± 0.8 | 10.9 ± 0.8 | 11.2 ± 0.6 | 0.167 |
| Interspinous distance (cm) | 8.7 ± 0.8 | 8.7 ± 0.8 | 8.2 ± 0.4 | 0.014 |
| Angle | 87.1 ± 8.5 | 87.8 ± 8.3 | 82.2 ± 8.4 | 0.008 |
| Angle | 45.0 ± 7.4 | 44.6 ± 7.4 | 48.0 ± 7.1 | 0.072 |
| Angle | 118.2 ± 9.7 | 117.4 ± 9.6 | 123.9 ± 8.1 | 0.008 |
| Angle | 109.2 ± 10.0 | 109.7 ± 10.1 | 106.0 ± 8.5 | 0.140 |
| Mesorectal area (cm2) | 26.9 ± 5.9 | 26.5 ± 6.0 | 29.6 ± 4.8 | 0.041 |
| Rectal area (cm2) | 7.7 ± 3.2 | 7.6 ± 3.3 | 8.1 ± 3.0 | 0.615 |
| Mesorectal fat area (cm2) | 19.1 ± 5.3 | 18.8 ± 5.4 | 21.5 ± 3.4 | 0.046 |
Data are expressed as the median ± standard deviation
LARC locally advanced rectal cancer, NCRT neoadjuvant chemoradiotherapy
Logistic regression analysis of predictors of high surgical difficulty in LaTME for LARC following NCRT
| Factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| Age | 0.957 (0.918–0.998) | 0.041 | 0.935 (0.872–1.003) | 0.062 |
| BMI | 1.416 (1.160–1.728) | 0.001 | 1.333 (0.999–1.779) | 0.051 |
| Distance from the anal verge | 0.719 (0.543–0.952) | 0.021 | 0.619 (0.409–0.938) | 0.024 |
| Previous abdominal surgery | 3.486 (0.814–14.934) | 0.093 | ||
| Tumor diameter | 2.975 (1.761–5.028) | < 0.001 | 3.747 (1.538–9.129) | 0.004 |
| Time interval from completion of radiation to surgery | 0.917 (0.650–1.295) | 0.624 | ||
| Pelvic inlet length | 1.265 (0.777–2.059) | 0.345 | ||
| Pubic tubercle height | 1.142 (0.297–4.399) | 0.847 | ||
| Pelvic outlet length | 1.443 (0.722–2.886) | 0.299 | ||
| Sacral length | 0.959 (0.629–1.464) | 0.848 | ||
| Sacral depth | 0.651 (0.238–1.775) | 0.401 | ||
| Pelvic depth | 1.499 (0.842–2.669) | 0.169 | ||
| Interspinous distance | 0.421 (0.208–0.852) | 0.016 | 0.127 (0.028–0.564) | 0.007 |
| Angle | 0.917 (0.858–0.979) | 0.010 | 0.821 (0.681–0.990) | 0.039 |
| Angle | 1.070 (0.993–1.153) | 0.075 | ||
| Angle | 1.082 (1.019–1.149) | 0.010 | 0.938 (0.807–1.090) | 0.404 |
| Angle | 0.960 (0.910–1.014) | 0.142 | ||
| Mesorectal area | 1.093 (1.003–1.191) | 0.043 | 0.833 (0.598–1.161) | 0.281 |
| Rectal area | 1.038 (0.899–1.197) | 0.612 | ||
| Mesorectal fat area | 1.103 (1.001–1.215) | 0.049 | 1.469 (0.978–2.206) | 0.064 |
LaTME Laparoscopic total mesorectal excision, LARC locally advanced rectal cancer, NCRT neoadjuvant chemoradiotherapy, OR odds ratio, CI confidence interval, BMI body mass index
Fig. 2A nomogram for predicting the probability of experiencing high surgical difficulty in LaTME for LARC following NCRT. a A nomogram for predicting high surgical difficulty in LaTME for LARC after NCRT. b Calibration curves for the nomogram with internal validation. LaTME Laparoscopic total mesorectal excision, LARC locally advanced rectal cancer, NCRT neoadjuvant chemoradiotherapy